ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,Y
3,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
4,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
5,1,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
6,1,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
7,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
7,2,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
8,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
8,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8,3,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,Y
9,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
10,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
11,1,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
12,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
12,2,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
12,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
13,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
13,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
14,1,Asphyxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,Y
14,2,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
15,1,Choreoathetosis,Choreiform movements,Movement disorders (incl parkinsonism),Nerv,N
15,2,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
16,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
17,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
18,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
18,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
18,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
18,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
18,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
19,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
19,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
20,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
20,2,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,Y
21,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
21,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
21,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
22,1,Congenital musculoskeletal disorder,Musculoskeletal disorders congenital NEC,Musculoskeletal and connective tissue disorders congenital,Cong,N
23,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
24,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
24,2,Phlebitis,Phlebitis NEC,Vascular infections and inflammations,Vasc,N
25,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
25,2,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
25,3,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
25,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
25,5,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
26,1,Apnoeic attack,Breathing abnormalities,Respiratory disorders NEC,Resp,N
27,1,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
27,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,Y
28,1,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
28,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,Y
29,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
30,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
30,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
30,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
31,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
32,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
33,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
34,1,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
35,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
35,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
36,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
36,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
37,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
38,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
38,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
38,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
38,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
38,5,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
38,6,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
38,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
39,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
40,1,Congenital ectopic bladder,Bladder disorders congenital,Renal and urinary tract disorders congenital,Cong,N
41,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
41,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
42,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
42,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
43,1,Headache,Headaches NEC,Headaches,Nerv,N
43,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
43,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
43,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
43,5,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
44,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
45,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
45,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
46,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
46,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
47,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
47,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
47,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
47,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
47,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
47,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
47,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
47,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
48,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
49,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
49,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
49,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
50,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
51,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
52,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
52,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
53,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
53,2,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
54,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
54,2,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
55,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
55,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
55,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
56,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
56,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
56,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
56,4,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
56,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
56,6,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
57,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,Y
58,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
59,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
59,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
59,3,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
59,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
60,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
61,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
61,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
62,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
63,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,Y
64,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
64,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
65,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
65,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
65,3,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
66,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
66,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
66,3,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
67,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
67,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
68,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
68,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
68,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
69,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,Y
69,2,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
70,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
70,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
71,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
71,2,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
72,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
72,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
72,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
73,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
73,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
74,1,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
75,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
76,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
76,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
76,3,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
76,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
76,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
77,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
77,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
77,3,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
78,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
78,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
78,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
78,4,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
79,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
80,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
80,2,Parkinsonism,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
80,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
81,1,Atrophy,Trophic disorders,Tissue disorders NEC,Genrl,N
81,2,Nail disorder,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
81,3,Scleroderma-like reaction,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
82,1,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
83,1,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
84,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
85,1,Congenital nystagmus,Neurological disorders congenital NEC,Neurological disorders congenital,Cong,N
85,2,Developmental delay,General signs and symptoms NEC,General system disorders NEC,Genrl,N
85,3,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
85,4,Microcephaly,Musculoskeletal and connective tissue disorders of skull congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
85,5,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
85,6,Posture abnormal,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
86,1,Congenital nystagmus,Neurological disorders congenital NEC,Neurological disorders congenital,Cong,N
86,2,Posture abnormal,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
86,3,Strabismus,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
86,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
87,1,Congenital nystagmus,Neurological disorders congenital NEC,Neurological disorders congenital,Cong,N
87,2,Developmental delay,General signs and symptoms NEC,General system disorders NEC,Genrl,N
88,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
88,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
89,1,Granuloma,Inflammations,General system disorders NEC,Genrl,N
90,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
90,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
91,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
91,2,Altered state of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
91,3,Anticonvulsant drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
91,4,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
91,5,Extensor plantar response,Abnormal reflexes,Neurological disorders NEC,Nerv,N
91,6,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
91,7,Hyperreflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
91,8,Hypertonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
91,9,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
91,10,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
91,11,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,Y
91,12,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
91,13,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
92,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,Y
92,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
92,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
93,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
93,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
93,3,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
94,1,Spinal cord injury,Spinal cord injuries NEC,Injuries NEC,Inj&P,N
95,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
95,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
95,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
96,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
96,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
96,3,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
96,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
96,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
97,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
98,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
98,2,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,Y
98,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
99,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
99,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
99,3,Prescribed overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
100,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
100,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
100,3,Peptic ulcer haemorrhage,Peptic ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
100,4,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
101,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
101,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
102,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
102,2,Coma,Coma states,Neurological disorders NEC,Nerv,N
102,3,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
102,4,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
102,5,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
102,6,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
102,7,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
102,8,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
103,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,Y
104,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
105,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
105,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
105,3,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
106,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
106,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
106,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
106,4,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
106,5,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
106,6,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
107,1,Arteriosclerosis coronary artery,Coronary artery disorders NEC,Coronary artery disorders,Card,N
107,2,Cardiovascular insufficiency,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
107,3,Conjunctival hyperaemia,"Conjunctival infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
107,4,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
107,5,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
107,6,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
107,7,Injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
107,8,Mouth haemorrhage,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
107,9,Needle track marks,Skin injuries and mechanical dermatoses,Epidermal and dermal conditions,Skin,N
107,10,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
107,11,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
107,12,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
107,13,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
107,14,Skin abrasion,Skin injuries NEC,Injuries NEC,Inj&P,N
107,15,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
107,16,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
108,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
108,2,Substance abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
108,3,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
109,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
109,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
109,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
110,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
110,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
110,3,Consciousness fluctuating,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
110,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
110,5,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
110,6,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
110,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
110,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
110,9,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
111,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
112,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
112,2,Cachexia,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
112,3,Circadian rhythm sleep disorder,Disturbances in sleep phase rhythm,Sleep disturbances (incl subtypes),Nerv,N
112,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
112,5,Consciousness fluctuating,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
112,6,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
112,7,Delirium,Deliria,Deliria (incl confusion),Psych,N
112,8,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
112,9,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
112,10,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
112,11,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
112,12,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
112,13,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
112,14,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
112,15,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
112,16,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
112,17,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
112,18,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
112,19,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
112,20,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
113,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
113,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
114,1,Congenital nystagmus,Neurological disorders congenital NEC,Neurological disorders congenital,Cong,N
114,2,Congenital visual acuity reduced,Ocular disorders congenital NEC,Eye disorders congenital,Cong,N
114,3,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
114,4,Neurodevelopmental disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
115,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
115,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
115,3,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,Y
116,1,Aortic arteriosclerosis,Aortic necrosis and vascular insufficiency,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
116,2,Arteriosclerosis coronary artery,Coronary artery disorders NEC,Coronary artery disorders,Card,N
116,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
116,4,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
117,1,Congenital visual acuity reduced,Ocular disorders congenital NEC,Eye disorders congenital,Cong,N
117,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
117,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
118,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
119,1,Arachnoid cyst,Nervous system cysts and polyps,Nervous system neoplasms benign,Nerv,N
120,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
120,2,Electrocardiogram ST segment abnormal,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
120,3,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
120,4,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
121,1,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
122,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
122,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
122,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
123,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
123,2,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
124,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
125,1,Arachnoid cyst,Nervous system cysts and polyps,Nervous system neoplasms benign,Nerv,N
126,1,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
127,1,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
128,1,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
128,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
129,1,Granuloma,Inflammations,General system disorders NEC,Genrl,N
130,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
130,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
131,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
132,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
133,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
133,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
133,3,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
134,1,Acute left ventricular failure,Left ventricular failures,Heart failures,Card,N
134,2,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
134,3,Arteriospasm coronary,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
134,4,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
134,5,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
134,6,Coronary artery dissection,Coronary artery disorders NEC,Coronary artery disorders,Card,N
134,7,Crepitations,General signs and symptoms NEC,General system disorders NEC,Genrl,N
134,8,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
134,9,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
134,10,Electrocardiogram ST segment depression,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
134,11,Electrocardiogram ST segment elevation,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
134,12,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
134,13,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
134,14,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
134,15,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
134,16,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
134,17,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
134,18,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
134,19,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
134,20,Troponin T increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
134,21,Ventricular hypokinesia,Myocardial disorders NEC,Myocardial disorders,Card,N
135,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
136,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
137,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
137,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
138,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
138,2,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
139,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
139,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
139,3,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
140,1,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
140,2,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
141,1,Developmental delay,General signs and symptoms NEC,General system disorders NEC,Genrl,N
141,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
141,3,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
141,4,Strabismus,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
141,5,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
142,1,Developmental delay,General signs and symptoms NEC,General system disorders NEC,Genrl,N
142,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
142,3,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
142,4,Strabismus,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
142,5,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
143,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
143,2,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
143,3,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
144,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
144,2,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
144,3,Strabismus,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
144,4,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
145,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
145,2,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
145,3,Strabismus,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
145,4,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
146,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
146,2,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
146,3,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
147,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
147,2,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
147,3,Strabismus,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
147,4,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
148,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
148,2,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
149,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
149,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
149,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
149,4,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
149,5,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
150,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
150,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
150,3,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
151,1,Acute hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
151,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
151,3,Substance use,Social issues NEC,Lifestyle issues,SocCi,N
152,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
152,2,Substance abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
153,1,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
154,1,Exposure via breast milk,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
154,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
155,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
155,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
156,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
156,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
157,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
157,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
158,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
158,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
159,1,Catheter site related reaction,Implant and catheter site reactions,Administration site reactions,Genrl,N
159,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
159,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
160,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
160,2,Product contamination physical,Product contamination and sterility issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
161,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
161,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
162,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
162,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
162,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
162,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
162,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
163,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
163,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
163,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
163,4,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
163,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
164,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
164,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
165,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
165,2,Respiratory rate decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
166,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
166,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
166,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
166,4,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
166,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
166,6,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
167,1,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
167,2,Aortic arteriosclerosis,Aortic necrosis and vascular insufficiency,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
167,3,Arteriosclerosis coronary artery,Coronary artery disorders NEC,Coronary artery disorders,Card,N
167,4,Bronchoalveolar lavage abnormal,Respiratory tract and thoracic histopathology procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
167,5,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
167,6,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
167,7,Fatty liver alcoholic,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
167,8,Kidney congestion,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
167,9,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
167,10,Pancreatic disorder,Pancreatic disorders NEC,Exocrine pancreas conditions,Gastr,N
167,11,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
167,12,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
167,13,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
168,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
168,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
168,3,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
169,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
169,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
169,3,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
170,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
170,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
170,3,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
170,4,Methaemoglobinaemia,Haematological disorders,Haematological disorders NEC,Blood,N
171,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
171,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
171,3,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
172,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
172,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
173,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
173,2,Chest expansion decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
173,3,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
173,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
173,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
173,6,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
173,7,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
173,8,Postmature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
173,9,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
173,10,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
173,11,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
174,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
174,2,Chest expansion decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
174,3,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
174,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
174,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
174,6,Maternal exposure timing unspecified,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
174,7,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
174,8,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
174,9,PCO2 decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
174,10,PO2 decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
174,11,Prolonged pregnancy,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
174,12,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
174,13,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
174,14,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
174,15,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
175,1,Aortic arteriosclerosis,Aortic necrosis and vascular insufficiency,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
175,2,Arteriosclerosis coronary artery,Coronary artery disorders NEC,Coronary artery disorders,Card,N
175,3,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
175,4,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
175,5,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
175,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
175,7,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
176,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
176,2,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
176,3,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
176,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
177,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
177,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
177,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
178,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
178,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
179,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
179,2,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
179,3,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
180,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
180,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
180,3,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
180,4,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
180,5,Glomerulosclerosis,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
180,6,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
180,7,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
180,8,Inflammation,Inflammations,General system disorders NEC,Genrl,N
180,9,International normalised ratio decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
180,10,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
180,11,Monocyte count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
180,12,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
180,13,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
180,14,Pneumoconiosis,Chest and respiratory tract injuries NEC,Injuries NEC,Inj&P,N
180,15,Portal tract inflammation,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
180,16,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
180,17,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
180,18,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
180,19,Visceral congestion,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
180,20,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
181,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
181,2,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
181,3,Peripartum cardiomyopathy,Pregnancy complicated by maternal disorders,Maternal complications of pregnancy,Preg,N
182,1,Congenital nystagmus,Neurological disorders congenital NEC,Neurological disorders congenital,Cong,N
182,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
182,3,Strabismus congenital,Ocular disorders congenital NEC,Eye disorders congenital,Cong,N
183,1,Congenital nystagmus,Neurological disorders congenital NEC,Neurological disorders congenital,Cong,N
183,2,Congenital visual acuity reduced,Ocular disorders congenital NEC,Eye disorders congenital,Cong,N
183,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
183,4,Strabismus congenital,Ocular disorders congenital NEC,Eye disorders congenital,Cong,N
184,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
185,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
185,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
186,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
186,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
186,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
187,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
187,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
187,3,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
188,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
188,2,Delayed recovery from anaesthesia,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
188,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
188,4,Lactation disorder,Lactation disorders,Breast disorders,Repro,N
188,5,Maternal distress during labour,Maternal complications of labour NEC,Maternal complications of labour and delivery,Preg,N
188,6,Motor dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
189,1,Anaesthetic complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
189,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
189,3,Delayed recovery from anaesthesia,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
189,4,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
189,5,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
189,6,Lactation disorder,Lactation disorders,Breast disorders,Repro,N
190,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
190,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
191,1,Hypopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
191,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
191,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
192,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
192,2,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
193,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
193,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
193,3,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
193,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
194,1,Alcohol abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
194,2,Substance abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
194,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
195,1,Confusion postoperative,Neurological and psychiatric procedural complications,Procedural related injuries and complications NEC,Inj&P,N
195,2,Mental status changes postoperative,Neurological and psychiatric procedural complications,Procedural related injuries and complications NEC,Inj&P,N
195,3,Metabolic alkalosis,Metabolic alkaloses,Acid-base disorders,Metab,N
195,4,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
196,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
197,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
197,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
197,3,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
197,4,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
197,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
198,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
199,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
200,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
200,2,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
201,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
201,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
202,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
202,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
202,3,Post lumbar puncture syndrome,Neurological and psychiatric procedural complications,Procedural related injuries and complications NEC,Inj&P,N
203,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
203,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
204,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
204,2,Exposure via breast milk,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
204,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
205,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
205,2,Exposure via breast milk,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
205,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
206,1,Laziness,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
206,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
207,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
207,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
208,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
208,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
209,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
209,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
210,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
210,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
211,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
212,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
212,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
212,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
212,4,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
213,1,Delivery,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
213,2,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
213,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
214,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
215,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
215,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
216,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
217,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
217,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
218,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
219,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
220,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
220,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
220,3,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
221,1,Substance abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,Y
222,1,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
222,2,Aspiration,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
222,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
222,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
222,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
223,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
223,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
224,1,Sudden cardiac death,Death and sudden death,Fatal outcomes,Genrl,Y
225,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
226,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
226,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
226,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
227,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
227,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
227,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
227,4,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
228,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
228,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
229,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
229,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
229,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
229,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
229,5,Tetany,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
230,1,Administration site urticaria,Administration site reactions NEC,Administration site reactions,Genrl,N
230,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
230,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
230,4,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
230,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
231,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
232,1,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
232,2,Respiratory rate decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
233,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
233,2,Obstructive sleep apnoea syndrome,Breathing abnormalities,Respiratory disorders NEC,Resp,Y
233,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
234,1,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
235,1,Pupil fixed,Pupil disorders,Ocular neuromuscular disorders,Eye,N
235,2,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,Y
236,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
236,2,Product odour abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
236,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
237,1,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,Y
238,1,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
239,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
239,2,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
240,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
240,2,Blood pressure systolic decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
240,3,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
241,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
241,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
242,1,Heart rate abnormal,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
242,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
242,3,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
243,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
243,2,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
244,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
244,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
245,1,Liquid product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
246,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
246,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
246,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
247,1,Accidental death,Death and sudden death,Fatal outcomes,Genrl,Y
247,2,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
247,3,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
248,1,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
248,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
248,3,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
248,4,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
249,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
250,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
251,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
251,2,Drug diversion,Criminal activity,Legal issues,SocCi,N
251,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
251,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
252,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
253,1,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
253,2,Uterine rupture,Reproductive system and breast injuries,Injuries NEC,Inj&P,N
254,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
254,2,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
254,3,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
254,4,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
254,5,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
255,1,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
255,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
255,3,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
256,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
256,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
257,1,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
257,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
258,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
259,1,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
259,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
259,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
259,4,Respiratory rate decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
259,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
259,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
259,7,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
260,1,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
260,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
261,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
261,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
261,3,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
261,4,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
261,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
262,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
262,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
262,3,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
263,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
263,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
263,3,Acute abdomen,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
263,4,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
263,5,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
263,6,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
263,7,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
263,8,Gastrointestinal necrosis,Gastrointestinal necrosis and gangrene (excl gangrenous hernia),Gastrointestinal vascular conditions,Gastr,N
263,9,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
263,10,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
263,11,Mucosal ulceration,Mucosal findings abnormal,General system disorders NEC,Genrl,N
263,12,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
263,13,Pneumoperitoneum,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
263,14,Rectal perforation,Anal and rectal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
263,15,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
263,16,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
264,1,Altered state of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
264,2,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
264,3,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
264,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
264,5,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
264,6,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
264,7,Pulmonary congestion,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
264,8,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
265,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
265,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
266,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
266,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
266,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
267,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
267,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
268,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
269,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
270,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
271,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
271,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
271,3,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
271,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
272,1,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
272,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
273,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
273,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
273,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
273,4,Incoherent,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
273,5,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
273,6,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
273,7,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
274,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
274,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
275,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
276,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
277,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
277,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
277,3,Precipitate labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
278,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
278,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
279,1,Alcohol poisoning,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
279,2,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
279,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
280,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
281,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
281,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
282,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
282,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
282,3,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
283,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
283,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
283,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
283,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
283,5,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
284,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
285,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
285,2,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,Y
285,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
285,4,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
285,5,Upper limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
286,1,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
287,1,Counterfeit product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
287,2,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,Y
287,3,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
287,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
287,5,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
287,6,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
287,7,Oxygen consumption decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
287,8,Prescription drug used without a prescription,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
288,1,Altered state of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
288,2,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
288,3,Gastric haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
288,4,Gastric perforation,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
288,5,Intra-abdominal haematoma,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
288,6,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
288,7,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
288,8,Pneumoperitoneum,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
288,9,Procedural pain,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
288,10,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
288,11,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
289,1,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
289,2,Concussion,Cerebral injuries NEC,Injuries NEC,Inj&P,N
289,3,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
289,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
289,5,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
289,6,Physical assault,Criminal activity,Legal issues,SocCi,N
289,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
289,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
290,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
290,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
290,3,Exposure via inhalation,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
291,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
291,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
291,3,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,Y
291,4,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
291,5,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
291,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
291,7,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
291,8,Snoring,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
292,1,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
292,2,Concussion,Cerebral injuries NEC,Injuries NEC,Inj&P,N
292,3,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
292,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
292,5,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
292,6,Physical assault,Criminal activity,Legal issues,SocCi,N
292,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
292,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
293,1,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
294,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,Y
294,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
295,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,Y
295,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
296,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,Y
296,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
297,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
297,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
298,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
298,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
299,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,Y
299,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
300,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
300,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
301,1,Alcohol interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
301,2,Coma,Coma states,Neurological disorders NEC,Nerv,N
301,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
301,4,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
301,5,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,Y
301,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
302,1,Hyporesponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
303,1,Alcohol interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
303,2,Coma,Coma states,Neurological disorders NEC,Nerv,N
303,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
303,4,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
303,5,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,Y
303,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
304,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
304,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
305,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,Y
306,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
307,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
308,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,Y
308,2,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
308,3,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
309,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
310,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
311,1,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
311,2,Maternal exposure during delivery,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
311,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
311,4,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
312,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
312,2,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
312,3,Hypoxic-ischaemic encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
312,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
313,1,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,N
313,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
313,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
313,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
314,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
315,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
315,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
315,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
315,4,Oculogyric crisis,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
315,5,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
316,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
317,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
318,1,Cardiopulmonary failure,Heart failures NEC,Heart failures,Card,Y
318,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
318,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
319,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
320,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
321,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
321,2,Consciousness fluctuating,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
321,3,Substance abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
321,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
322,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
322,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
322,3,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,Y
322,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
322,5,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
323,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
324,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
325,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
325,2,Tension,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
325,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
326,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
327,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
327,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
328,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
329,1,Apnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
329,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
329,3,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
330,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
330,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
330,3,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
331,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
331,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
332,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
332,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
333,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
333,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
334,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
334,2,Bone loss,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
334,3,Dental caries,Dental and periodontal infections and inflammations,Dental and gingival conditions,Gastr,N
334,4,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
334,5,Gingivitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
334,6,Oropharyngeal plaque,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
334,7,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
334,8,Periodontitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
334,9,Poor personal hygiene,Social issues NEC,Lifestyle issues,SocCi,N
334,10,Salivary hyposecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
334,11,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
335,1,Alcohol interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
335,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
335,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
335,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
335,5,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
335,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
335,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
336,1,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,Y
336,2,Cardiomegaly,Myocardial disorders NEC,Myocardial disorders,Card,N
336,3,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
337,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
337,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
338,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
338,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
339,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
339,2,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
340,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
341,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
341,2,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
341,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
341,4,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
341,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
341,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
342,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
343,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
344,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
344,2,Exposure via breast milk,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
344,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
345,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
345,2,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
345,3,Substance abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
346,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
346,2,Congenital nose malformation,Nasal disorders congenital,Respiratory disorders congenital,Cong,N
346,3,Constipation neonatal,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
346,4,Delayed visual maturation,Neurologic visual problems NEC,Neurological disorders of the eye,Nerv,N
346,5,Developmental delay,General signs and symptoms NEC,General system disorders NEC,Genrl,N
346,6,Dysmorphism,Musculoskeletal disorders congenital NEC,Musculoskeletal and connective tissue disorders congenital,Cong,N
346,7,Foetal chromosome abnormality,Chromosomal abnormalities NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
346,8,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
346,9,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
346,10,Gene mutation,Gene mutations and other alterations NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
346,11,Hypermetropia,Refractive and accommodative disorders,Vision disorders,Eye,N
346,12,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
346,13,Hypotonia neonatal,Muscle tone abnormalities,Muscle disorders,Musc,N
346,14,Motor developmental delay,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
346,15,Normocytic anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
346,16,Renal hypoplasia,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
346,17,Resistance to thyroid hormone,Thyroid disorders congenital,Endocrine disorders congenital,Cong,N
346,18,Short stature,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
346,19,Speech disorder developmental,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
346,20,Thyroxine decreased,Thyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
346,21,Tri-iodothyronine increased,Thyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
347,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
348,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
349,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
349,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
349,3,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
349,4,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
349,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
349,6,Spinal cord injury,Spinal cord injuries NEC,Injuries NEC,Inj&P,N
350,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
350,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
350,3,Spinal cord injury,Spinal cord injuries NEC,Injuries NEC,Inj&P,N
351,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
351,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
351,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
351,4,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
351,5,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
352,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
352,2,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
352,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
353,1,Antipsychotic drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
353,2,Aortic arteriosclerosis,Aortic necrosis and vascular insufficiency,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
353,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
354,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
355,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
355,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
355,3,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
356,1,Acute cardiac event,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,Y
356,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
356,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
356,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
356,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
357,1,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
357,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
358,1,Arteriovenous fistula,Vascular malformations and acquired anomalies,Vascular disorders NEC,Vasc,N
358,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
358,3,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
358,4,Septic pulmonary embolism,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
359,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
360,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
360,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
361,1,Near death experience,Perception disturbances NEC,Disturbances in thinking and perception,Psych,Y
362,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
362,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
363,1,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
363,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
363,3,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
363,4,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
364,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
364,2,Foetal heart rate deceleration abnormality,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
364,3,Foetal monitoring abnormal,Foetal and neonatal diagnostic procedures,Foetal and neonatal investigations,Inv,N
364,4,Hypoglycaemia neonatal,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
364,5,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
365,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
366,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
367,1,Exposure via breast milk,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
367,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
367,3,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
368,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
369,1,Aortic arteriosclerosis,Aortic necrosis and vascular insufficiency,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
369,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
369,3,Postmortem blood drug level increased,Toxicology laboratory analyses,Toxicology and therapeutic drug monitoring,Inv,N
369,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
369,5,Uterine leiomyoma,Uterine neoplasms benign,Reproductive neoplasms female benign,Neopl,N
370,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
370,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
371,1,Alcohol interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
371,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
371,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
371,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
371,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
372,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
372,2,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
373,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
373,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
374,1,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,Y
374,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
375,1,Arteriosclerosis,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
375,2,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
375,3,Left ventricular hypertrophy,Myocardial disorders NEC,Myocardial disorders,Card,N
375,4,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
375,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
376,1,Arteriosclerosis coronary artery,Coronary artery disorders NEC,Coronary artery disorders,Card,Y
376,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
377,1,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,Y
377,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
378,1,Arteriosclerosis,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,Y
378,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
379,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
380,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
381,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
381,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
381,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
382,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
382,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
382,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
383,1,Maternal exposure during delivery,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
383,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
384,1,Maternal exposure before pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
384,2,Maternal exposure during delivery,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
385,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
385,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
385,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
386,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
387,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
387,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
387,3,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
388,1,Behaviour disorder,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
388,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
388,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
389,1,Behaviour disorder,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
389,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
389,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
389,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
390,1,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
390,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
390,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
391,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
391,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
391,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
392,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
392,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
393,1,Drug use disorder,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
393,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
394,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
394,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
394,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
395,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
395,2,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
396,1,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
396,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
397,1,Arteriosclerosis,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
397,2,Aspiration,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,Y
397,3,Cardiomegaly,Myocardial disorders NEC,Myocardial disorders,Card,N
397,4,Emphysema,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
397,5,Left ventricular hypertrophy,Myocardial disorders NEC,Myocardial disorders,Card,N
397,6,Nephrosclerosis,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
397,7,Pneumoconiosis,Chest and respiratory tract injuries NEC,Injuries NEC,Inj&P,N
397,8,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
397,9,Portal tract inflammation,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
397,10,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
397,11,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
398,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
398,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
399,1,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
399,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
400,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
401,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
401,2,Pruritus allergic,Pruritus NEC,Epidermal and dermal conditions,Skin,N
402,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
402,2,Pruritus allergic,Pruritus NEC,Epidermal and dermal conditions,Skin,N
403,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
403,2,Pruritus allergic,Pruritus NEC,Epidermal and dermal conditions,Skin,N
404,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
404,2,Pruritus allergic,Pruritus NEC,Epidermal and dermal conditions,Skin,N
405,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
405,2,Pruritus allergic,Pruritus NEC,Epidermal and dermal conditions,Skin,N
406,1,Anaesthetic complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
406,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
407,1,Arachnoiditis,Central nervous system inflammatory disorders NEC,Central nervous system infections and inflammations,Nerv,N
407,2,Cauda equina syndrome,Lumbar spinal cord and nerve root disorders,Spinal cord and nerve root disorders,Nerv,N
407,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
407,4,Maternal exposure during delivery,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
407,5,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
407,6,Motor dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
407,7,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
407,8,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
407,9,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
407,10,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
407,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
407,12,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
407,13,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
408,1,Infective exacerbation of chronic obstructive airways disease,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
409,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
